Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Harris (1992)
Parvovirus B19 for the hematologistAmerican Journal of Hematology, 39
E. Morita, A. Nakashima, H. Asao, Hiroyuki Sato, K. Sugamura (2003)
Human Parvovirus B19 Nonstructural Protein (NS1) Induces Cell Cycle Arrest at G1 PhaseJournal of Virology, 77
N. Frickhofen, Z. Chen, N. Young, B. Cohen, H. Heimpel, J. Abkowitz (1994)
Parvovirus B19 as a cause of acquired chronic pure red cell aplasiaBritish Journal of Haematology, 87
C. Potter, A. Potter, C. Hatton, H. Chapel, M., J., Anderson, R. Pattison, J. D.A., Tyrrell, P., G., Higgins, S. Willman, F. H., Parry (1987)
Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).The Journal of clinical investigation, 79 5
K. Brown, N. Young, J. Liu (1994)
Molecular, cellular and clinical aspects of parvovirus B19 infection.Critical reviews in oncology/hematology, 16 1
C. Doerig, B. Hirt, J. Antonietti, P. Beard (1990)
Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcriptionJournal of Virology, 64
V. Lukashov, J. Goudsmit (2001)
Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian ParvovirusesJournal of Virology, 75
J. Abkowitz, K. Brown, R. Wood, N. Kovach, S. Green, N. Young (1997)
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection.The Journal of infectious diseases, 176 1
F. Numa, K. Hirabayashi, N. Tsunaga, H. Kato, K. O’Rourke, H. Shao, Connie Stechmann-Lebakken, J. Varani, A. Rapraeger, V. Dixit (1995)
Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.Cancer research, 55 20
K. Landsteiner, P. Levine (1927)
Further Observations on Individual Differences of Human Blood.Proceedings of the Society for Experimental Biology and Medicine, 24
J. Nemunaitis, N. Senzer, C. Cunningham, Thomas Dubensky (2001)
Virus-mediated killing of cells that lack p53 activity.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 4 5
J. Kelleher, N. Luban, P. Mortimer, T. Kamimura (1983)
Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis.The Journal of pediatrics, 102 5
A. Beeck, J. Sobczak-Thépot, H. Sirma, F. Bourgain, C. Bréchot, P. Caillet-Fauquet (2001)
NS1- and Minute Virus of Mice-Induced Cell Cycle Arrest: Involvement of p53 and p21cip1Journal of Virology, 75
A. Morey, K. Fleming (1992)
Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitroBritish Journal of Haematology, 82
N. Yaegashi, H. Shiraishi, T. Takeshita, M. Nakamura, A. Yajima, K. Sugamura (1989)
Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liverJournal of Virology, 63
Mitsuyasu Mitsuyasu, Lambertus Lambertus, Goetz Goetz (1992)
Transfusion‐dependent anemia in a patient with AIDS (Infectious Disease Rounds)Clin Infect Dis, 15
S. Naides, C. Weiner (1989)
Antenatal diagnosis and palliative treatment of non‐immune hydrops fetalis secondary to fetal parvovirus B19 infectionPrenatal Diagnosis, 9
Y. Sadahira, T. Sugihara, Y. Yawata (2001)
Expression of p53 and Ki-67 Antigen in Bone Marrow Giant Proerythroblasts Associated With Human Parvovirus B19 InfectionInternational Journal of Hematology, 74
E. Santagostino, P. Mannucci, A. Gringeri, A. Azzi, M. Morfini (1994)
Eliminating parvovirus B19 from blood productsThe Lancet, 343
N. Yageashi, Takenari Niinuma, H. Chisaka, Tatsuya Watanabe, S. Uehara, K. Okamura, S. Moffatt, K. Sugamura, A. Yajima (1998)
The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis.The Journal of infection, 37 1
N. Frickhofen, N. Young (1989)
Persistent parvovirus B19 infections in humans.Microbial pathogenesis, 7 5
N. Young, M. Harrison, J. Moore, P. Mortimer, R. Humphries (1984)
Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro.The Journal of clinical investigation, 74 6
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
B. Lindton, T. Tolfvenstam, O. Norbeck, L. Markling, O. Ringdén, M. Westgren, K. Broliden (2000)
Recombinant Parvovirus B19 Empty Capsids Inhibit Fetal Hematopoietic Colony Formation in vitroFetal Diagnosis and Therapy, 16
K. Brown, S. Green, J. Mayolo, N. Young, J. Bellanti, S. Smith, Tj Smith (1994)
Congenital anaemia after transplacental B19 parvovirus infectionThe Lancet, 343
P. Mortimer, R. Humphries, J. Moore, R. Purcell, N. Young (1983)
A human parvovirus-like virus inhibits haematopoietic colony formation in vitroNature, 302
A. Morey, D. Ferguson, K. Fleming (1993)
Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosisThe Journal of Pathology, 169
K. Brown, S. Anderson, N. Young (1993)
Erythrocyte P antigen: cellular receptor for B19 parvovirus.Science, 262 5130
D. Pillay, G. Patou, P. Griffiths, L. Rees (1991)
Secondary parvovirus B19 infection in an immunocompromised child.The Pediatric infectious disease journal, 10 8
F. Gottlieb, J. Deutsch (1992)
Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection.The American journal of medicine, 92 3
K. Ozawa, J. Ayub, S. Kajigaya, T. Shimada, N. Young (1988)
The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cellsJournal of Virology, 62
N. Young, J. Abkowitz, L. Luzzatto (2000)
New Insights into the Pathophysiology of Acquired Cytopenias.Hematology. American Society of Hematology. Education Program
E. Bertoni, A. Rosati, M. Zanazzi, A. Azzi, K. Zakrzewfka, S. Guidi, M. Salvadori (1995)
Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 10 8
N. Frickhofen, J. Abkowitz, M. Safford, J. Berry, J. Antunez-de-Mayolo, A. Astrow, Robert Cohen, I. Halperin, L. King, D. Mintzer, B. Cohen, N. Young (1990)
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.Annals of internal medicine, 113 12
J. Lefrère, M. Mariotti, M. Thauvin (1994)
B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentratesThe Lancet, 343
N. Sol, J. Junter, I. Vassias, J. Freyssinier, A. Thomas, A. Prigent, B. Rudkin, S. Fichelson, F. Morinet (1999)
Possible Interactions between the NS-1 Protein and Tumor Necrosis Factor Alpha Pathways in Erythroid Cell Apoptosis Induced by Human Parvovirus B19Journal of Virology, 73
K. Starling, D. Fernbach (1973)
Hypoplastic anemia.The Journal of pediatrics, 82 4
L. Cooling, D. Zhang, K. Walker, T. Koerner (1995)
Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins.Glycobiology, 5 6
H. Porter, A. Quantrill, K. Fleming (1988)
B19 PARVOVIRUS INFECTION OF MYOCARDIAL CELLSThe Lancet, 331
P. Owren (1948)
Congenital hemolytic jaundice; the pathogenesis of the hemolytic crisis.Blood, 3 3
I. Sturm, B. Watschinger, K. Geissler, S. Guber, T. Popow-Kraupp, W. Horl, E. Pohanka (1996)
Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 11 7
E. Morita, K. Tada, H. Chisaka, H. Asao, Hiroyuki Sato, N. Yaegashi, K. Sugamura (2001)
Human Parvovirus B19 Induces Cell Cycle Arrest at G2 Phase with Accumulation of Mitotic CyclinsJournal of Virology, 75
K. Searle, G. Schalasta, G. Enders (1998)
Development of antibodies to the nonstructural Protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: Implications for pathogenesis doubtfulJournal of Medical Virology, 56
R. Mitsuyasu, M. Lambertus, M. Goetz (1992)
Transfusion-dependent anemia in a patient with AIDS.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 15 3
K. Broliden, T. Tolfvenstam, Staffan Ohlsson, J. Henter (1998)
Persistent B19 parvovirus infection in pediatric malignancies.Medical and pediatric oncology, 31 2
N. Uemura, K. Ozawa, K. Tani, M. Nishikawa, S. Inoue, T. Nagao, H. Uchida, Y. Matsunaga, S. Asano (1995)
Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipientEuropean Journal of Haematology, 54
K. Ozawa, N. Young (1987)
Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell culturesJournal of Virology, 61
Y. Cossart, B. Cant, A. Field, D. Widdows (1975)
PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 305
A. Corcoran, Sean Doyle, Dave Waldron, A. Nicholson, B. Mahon (2000)
Impaired Gamma Interferon Responses against Parvovirus B19 by Recently Infected ChildrenJournal of Virology, 74
Summerford Summerford, Bartlett Bartlett, Samulski Samulski (1992)
AlphaVbeta5 integrin: a c0‐receptor for adeno‐associated virus type 2 infectionNat Med, 5
Fisch Fisch, Handgretinger Handgretinger, Schaefer Schaefer (2000)
Pure red cell aplasiaBr J Haematol, 111
N. Yaegashi, Takenari Niinuma, H. Chisaka, S. Uehara, S. Moffatt, K. Tada, M. Iwabuchi, Y. Matsunaga, M. Nakayama, C. Yutani, Y. Osamura, Emi Hirayama, K. Okamura, K. Sugamura, A. Yajima (1999)
Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo.The Journal of infection, 39 1
M. Lambot, Jean Noël, M. Peny, Frédéric Rodesch, Jules Haot (1999)
Fetal parvovirus B19 infection associated with myocardial necrosisPrenatal Diagnosis, 19
K. Brown, N. Young (1995)
Parvovirus B19 infection and hematopoiesis.Blood reviews, 9 3
L. Coulombel, F. Morinet, F. Miélot, G. Tchernia, A. Knisely, P. Shlossman, J. Davidson, B. Gibson, A. Gibson, T. Evans (1989)
PARVOVIRUS INFECTION, LEUKAEMIA, AND IMMUNODEFICIENCYThe Lancet, 333
Takahashi Takeshi, K. Ozawa, Keisuke Takahashi, S. Asano, F. Takaku (1990)
Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation.Blood, 75 3
T. Wong, P. Chan, C. Leung, C. Szeto, J. Tam, P. Li (1999)
Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.American journal of kidney diseases : the official journal of the National Kidney Foundation, 34 6
Coralie Pallier, Anna Greco, J. Junter, Ali Saib, Isabelle Vassias, Frédéric Morinet (1997)
The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cellsJournal of Virology, 71
Kirsten Weigel-Kelley, M. Yoder, A. Srivastava (2001)
Recombinant Human Parvovirus B19 Vectors: Erythrocyte P Antigen Is Necessary but Not Sufficient for Successful Transduction of Human Hematopoietic CellsJournal of Virology, 75
S. Moffatt, N. Yaegashi, K. Tada, N. Tanaka, K. Sugamura (1998)
Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage CellsJournal of Virology, 72
E. Carper, G. Kurtzman (1996)
Human parvovirus B19 infectionCurrent Opinion in Hematology, 3
K. Brown, J. Hibbs, G. Gallinella, S. Anderson, E. Lehman, P. McCarthy, N. Young (1994)
Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).The New England journal of medicine, 330 17
M. Momoeda, S. Wong, M. Kawase, N. Young, S. Kajigaya (1994)
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicityJournal of Virology, 68
S. Rosenfeld, K. Yoshimoto, S. Kajigaya, S. Anderson, N. Young, A. Field, P. Warrener, G. Bansal, M. Collett (1992)
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.The Journal of clinical investigation, 89 6
M. Anderson, P. Higgins, L. Davis, J. Willman, S. Jones, I. Kidd, J. Pattison, D. Tyrrell (1985)
Experimental parvoviral infection in humans.The Journal of infectious diseases, 152 2
D. Geetha, James Zachary, Helen Baldado, J. Kronz, E. Kraus (2000)
Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literatureClinical Transplantation, 14
Tamara Brown, A. Anand, L. Ritchie, J. Clewley, T. Reid (1984)
INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALISThe Lancet, 324
A. Girod, M. Ried, C. Wobus, H. Lahm, K. Leike, J. Kleinschmidt, G. Deléage, M. Hallek (1999)
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2Nature Medicine, 5
P. Caillet-Fauquet, M. Perros, A. Brandenburger, P. Spegelaere, J. Rommelaere (1990)
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non‐structural proteins.The EMBO Journal, 9
E. Fortunato, D. Spector (2003)
Viral induction of site‐specific chromosome damageReviews in Medical Virology, 13
J. Saldanha, P. Minor (1996)
Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufactureBritish Journal of Haematology, 93
P. Koduri (1998)
Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infectionAmerican Journal of Hematology, 58
R. Levy, A. Weissman, Gary Blomberg, Z. Hagay (1997)
Infection by parvovirus B 19 during pregnancy: a review.Obstetrical & gynecological survey, 52 4
K. Ozawa, G. Kurtzman, N. Young (1987)
Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro.Blood, 70 2
Sarah Ball, Colin McGuckin, G. Jenkins, E. Gordon-Smith (1996)
Diamond‐Blackfan anaemia in the U.K.: analysis of 80 cases from a 20‐year birth cohortBritish Journal of Haematology, 94
Elizabeth Miller, C. Fairley, B. Cohen, C. Seng (1998)
Immediate and long term outcome of human parvovirus B19 infection in pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 105
K. Brown, N. Young (1997)
Parvovirus B19 in human disease.Annual review of medicine, 48
L. Diamond, W. Wang, B. Alter (1976)
Congenital hypoplastic anemia.Advances in pediatrics, 22
W. El-Deiry, T. Tokino, V. Velculescu, D. Levy, R. Parsons, J. Trent, D. Lin, W. Mercer, K. Kinzler, B. Vogelstein (1993)
WAF1, a potential mediator of p53 tumor suppressionCell, 75
A. Morey, J. Keeling, H. Porter, K. Fleming (1992)
Clinical and histopathological features of parvovirus B19 infection in the human fetusBJOG: An International Journal of Obstetrics & Gynaecology, 99
Diamond Lk, Wang Wc, Alter Bp (1957)
CONGENITAL hypoplastic anemia.Nutrition reviews, 15 7
M. Naiki, J. Fong, R. Ledeen, D. Marcus (1975)
Structure of the human erythrocyte blood group P1 glycosphingolipid.Biochemistry, 14 22
Marcus Dm, Kundu Sk, A. Suzuki (1981)
The P blood group system: recent progress in immunochemistry and genetics.Seminars in hematology, 18 1
C. Prowse, C. Ludlam, P. Yap (1997)
Human Parvovirus B19 and Blood ProductsVox Sanguinis, 72
Diamond Diamond, Blackfan Blackfan (1938)
Hypoplastic anemiaAm J Dis Child, 46
H. Chisaka, E. Morita, K. Murata, N. Ishii, N. Yaegashi, K. Okamura, K. Sugamura (2002)
A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19.The Journal of general virology, 83 Pt 2
A. Lundqvist, T. Tolfvenstam, M. Brytting, C. Stolt, K. Hedman, K. Broliden (1999)
Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.Scandinavian journal of infectious diseases, 31 2
N. Moreux, B. Ranchin, A. Calvet, G. Bellon, H. Levrey-Hadden (2002)
Chronic parvovirus B19 infection in a pediatric lung transplanted patient.Transplantation, 73 4
C. Summerford, J. Bartlett, R. Samulski (1999)
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infectionNature Medicine, 5
P. Rouger, P. Gane, C. Salmon (1987)
Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies.Revue francaise de transfusion et immuno-hematologie, 30 5
J. Ramage, A. Hale, E. Gane, B. Cohen, M. Boyle, G. Mufti, Roger Williams (1994)
Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulinThe Lancet, 343
Human parvovirus B19 (B19) infection causes human bone marrow failure, by affecting erythroid‐lineage cells which are well‐known target cells for B19. The anaemia induced by B19 infection is of minor clinical significance in healthy children and adults, however, it becomes critical in those afflicted with haemolytic diseases. This condition is called transient aplastic crisis, and the pathogenesis is explained by the short life‐span of red blood cells. Similarly, fetuses are thought to be severely affected by B19‐intrauterine infection in the first and second trimester, as the half‐life of red blood cells is apparently shorter than RBC at the bone marrow haematopoietic stage. On the other hand, B19 is also the causative agent of persistent anaemia in immunocompromised patients, transplant recipients and infants. The deficiencies of appropriate immune responses to B19 impair viral elimination in vivo, which results in enlargement of B19‐infected erythroid‐lineage cells. The B19‐associated damage of erythroid lineage cells is due to cytotoxicity mediated by viral proteins. B19‐infected erythroid‐lineage cells show apoptotic features, which are thought to be induced by the non‐structural protein, NS1, of B19. In addition, B19 infection induces cell cycle arrests at the G1 and G2 phases. The G1 arrest is induced by NS1 expression prior to apoptosis induction in B19‐infected cells, while the G2 arrest is induced not only by infectious B19 but also by UV‐inactivated B19, which lacks the ability to express NS1. In this review, we address the clinical manifestations and molecular mechanisms for B19‐induced anaemia in humans and a mouse model, and of B19‐induced cell cycle arrests in erythroid cells. Copyright © 2003 John Wiley & Sons, Ltd.
Reviews in Medical Virology – Wiley
Published: Nov 1, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.